Shane Barton insider trades
Open-market stock purchases and sales by Shane Barton, Principal Accounting Officer at BioAge Labs, Inc, from SEC Form 4 filings since Feb 26, 2021.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +39%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 30, 2026 | BIOA BioAge Labs, Inc | Sold | $509K |
| Jun 30, 2026 | BIOA BioAge Labs, Inc | Bought (not open market) | — |
| Jun 30, 2026 | BIOA BioAge Labs, Inc | Bought (not open market) | — |
| Jun 30, 2026 | BIOA BioAge Labs, Inc | Bought (not open market) | — |
| Jun 30, 2026 | BIOA BioAge Labs, Inc | Bought (not open market) | — |
| Jun 29, 2026 | BIOA BioAge Labs, Inc | Sold | $1.1M |
| Jun 29, 2026 | BIOA BioAge Labs, Inc | Bought (not open market) | — |
| Jun 29, 2026 | BIOA BioAge Labs, Inc | Bought (not open market) | — |
| Jun 29, 2026 | BIOA BioAge Labs, Inc | Bought (not open market) | — |
| Jun 29, 2026 | BIOA BioAge Labs, Inc | Bought (not open market) | — |
| Feb 17, 2026 | BIOA BioAge Labs, Inc | Bought (not open market) | — |